Cardiac Surgery Overview
    CURRICULUM VITAE

Marc R. Katz M.D., M.P.H.

Marc R. Katz M.D., M.P.H.

Business Address:
Cardiac Surgery Specialists
5875 Bremo Road, Suite G5
Richmond, Virginia 23226

Phone:
804-287-7840

Email: MKatz@roboticheartsurgery.info

EDUCATION/HONORS:

1977-81 Tulane Medical School, New Orleans, Louisiana
  Doctor of Medicine (1981)
  Master of Public Health (1981)
  Research Student, Department of Surgery (1980); Ronald C. Nichols, M.D.
  Department of Surgery, National Public Health Service (1978)
 
      New Orleans Public Health Hospital, New Orleans, Louisiana; COSTEP Program
1974-77 Adelphi University, Garden City, New York
  Bachelor of Arts, Magna Cum Laude; Departmental Honors in Biology (1977)
  Beta Beta Beta (1977)
  Research Student, Department of Biology; John K. Hampton, Ph.D.
1973-74 Hobart College, Geneva, New York
  New York State Regents College Scholarship (1973)


POSTGRADUATE TRAINING:


The Children’s Hospital, Boston, Massachusetts
    Department of Cardiac Surgery; Aldo R. Castaneda, M.D.
        7-12/88 Senior Resident, Pediatric Cardiac Surgery

Medical College of Virginia, Richmond, Virginia
    Division of Cardiothoracic Surgery; Richard R. Lower, M.D.
        1986-88 Cardiothoracic Surgery Fellow
    Department of Surgery; Lazar J. Greenfield, M.D
        1985-86 Chief Resident
        1984-85 Senior Assistant Resident
        1983-84 Assistant Resident
        1982-83 Junior Assistant Resident
        1981-82 Internship


BOARD CERTIFICATIONS:

Fellow, American College of Surgeons
American Board of Thoracic Surgery
American Board of Surgery
Fellow, American College of Cardiology


SIGNIFICANT ACCOMPLISHMENTS:

April 2004: First continuous flow (MicroMed DeBakey) VAD in Virginia
Oct., 2003: HCA Surgeon of the Year
Sept. 2002: Performed the first Totally Endoscopic Coronary Artery Bypass procedure in Virginia
March 2001: Performed first FDA approved Robotically Assisted Thoracic Surgical procedure in the United States
May, 1997: Performed the first Transmyocardial Revascularization (TMR) procedure in Virginia.
July, 1990: Performed the first Left Ventricular Assist Device (LVAD) procedure in Virginia.
Oct., 1989: Performed the first heart transplant in a community hospital in Virginia.
Feb. 1989: Performed the first Heart-Kidney transplant in the eastern United States.
Performed over 200 heart transplants.
Established and served as Director of the Virginia Transplant Center 8/89-6/06


APPOINTMENTS:

10/06 - Medical Director, Bon Secours Heart & Vascular Institute
1/05 - Society of Thoracic Surgeons National Workforce on New Technology
1999 – 2000 Chief of Staff, Henrico Doctors’ Hospital, Richmond, Virginia
1997 – 1999 Chief of Surgery, Henrico Doctors’ Hospital, Richmond, Virginia
1991 – present Chief of Cardiac Surgery, Henrico Doctors’ Hospital, Richmond, Virginia
6/89 – 6/2002 Board of Directors, LifeNet Transplant Services
8/89 – 6/2006 Director of Cardiac Transplantation, Virginia Transplant Center, Richmond, Virginia


MEMBERSHIPS:

Society of Thoracic Surgeons
International Society for Heart Transplantation
International Society for Minimally Invasive Cardiac Surgery
American Society of Transplant Surgeons
American Medical Association
American College of Surgeons
Humera Surgical Society
Richmond Academy of Medicine
Medical Society of Virginia
Virginia Surgical Society


RESEARCH:

Principal Investigator:
1. Use of the Thoratec Ventricular Assist Device System as a Bridge to Cardiac Transplantation. IDE G810203
2. Use of Rabbitt Anti-Human Thymocyte Globulin for Prophylaxis and Treatment of Allograft Rejection in Cardiac Transplantation.
3. Secondary Prospective Study for the Evaluation and Safety of Cryopreserved Human Allograft Heart Valves.
4. The Use of Inhaled Nitric Oxide for the Treatment of Pulmonary Hypertension.
5. Transmyocardial Revascularization (TMR) using the Heart Laser CO2 Laser System as an Alternative to Repeat Coronary Artery Bypass Surgery.
6. Multicenter Trial of Robotically Assisted Totally Endoscopic Coronary Artery Bypass Surgery.
7. Clinical Investigation of the MicroMed DeBakey VAD for Bridge to Transplantation in Patients with End Stage Heart Failure.
8. Evaluation of Internal Mammary Arteries, Coronary Arteries and Anastomosis by Epicardial Ultrasound During Off-Pump Coronary Artery Bypass Surgery.
9. Coronary Artery Revascularization Evalualtion (CARE). A Multi-Center Registry.
10. Integrated Coronary Revascularization: Percutaneous Coronary Intervention plus Robotic Totally Endoscopic Coronary Artery Bypass.
11. Phase III Randomized, Double-Blind, Parallel-Group Placebo Controlled Study of the Effect of Pexelizumab in Patients Undergoing Coronary Artery Bypass Surgery with Cardiopulmonary Bypass. PRIMO-CABG trial.


ABSTRACTS:

Katz, MR; Goldman, MH; Barnhart, GR; et al.: Pretransplant Transfusions in Cardiac Allograft Recipients.
Circulation 70(Suppl 2), 1984, p 173.

Katz, MR; Szentpetery, S; Thompson, JA; et al.: Are Steroids Essential for Successful Maintenance of Immunosuppression in Heart Transplantation?
J Heart Transplant 5(5), 1986, p 395.

Brown, P; Katz, M; Kugelmass, A; Simon, A; Battaglia, S; Tarkington, L; Becker, E; Culler, S: Comparisons Among CABG Patients Receiving All Arterial, All Venous, or Mixed Grafts: Does It Make a Difference in Immediate Clinical Outcomes? Transcatheter Therapeutics, September 2003.

Mack, M; Katz, M; Kugelmass, A; Zocco, J; et.al.: Is the Timing of CABG Surgery Following AMI Associated with A Difference in Mortality? American College of Cardiology, March 2004

Mack, M; Katz, M; Zocco, J; Wolfgang, T; et.al. : Are Higher Creatinine Levels a Predictor of Mortality Among Patients Undergoing CABG Surgery? CTT March 2004

Anderson, A; Kugelmass, A; Katz, M; et.al.: Does Having a CHF Program Make a Difference? American Heart Association Outcomes. May 2004

Kugelmass, A; Anderson, A; Katz, M; et.al. : POC Biomarkers: Does it Make a Difference in AMI Outcomes? American Heart Association Outcomes. May 2004

Macris, M; Katz, M; Brown, P; et.al. : Outcomes and Costs of CABG Patients with a Primary Diagnosis of AMI in Community Based Hospitals. American Heart Association 6th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke. May 2005

Katz, MR; Van Praet, F; de Canniere, D; et al. : Integrated Coronary Revascularization: Percutaneous Coronary Intervention plus Robotic Totally Endoscopic Coronary Artery Bypass. Circulation 112 (17) Supplement, October 25, 2005, pII665

Mack, MJ; Herbert, MA; Prince, SL; Katz, MR; et.al; Current One-Year Clinical Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: The CARE (Coronary Artery Revascularization) Study. American Heart Association 7th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke. May 2006

Mack, MJ; Brown, P; Katz, MR; et.al: Current Eighteen Month Clinical Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: The CARE (Coronary Artery Revascularization) Study. Society of Thoracic Surgeons 43rd Annual Meeting January 2007


PUBLICATIONS:

Barnhart, GR; Hastillo, A; Goldman, MH; Katz, MR; Szentpetery, S; Wolfgang, TC; Mohanakumar, T; Lower, RR; Hess, ML: A Prospective Randomized Trial of Pretransfusion-Azathioprine-Prednisone versus Cyclosporine-Prednisone Immunosuppression in Cardiac Transplant Recipients: Preliminary Results. Circ 72 (Suppl 2), 227, 1985.

Katz, MR; Barnhart, GR; Goldman, MH; et al.: Pretransplant Transfusions in Cardiac Allograft Recipients. Transplantation 43(4), 499, 1987.

Katz, MR; Barnhart, GR; Szentpetery, S; et al.: Are Steriods Essential for Maintenance of Immunosuppression in Heart Transplantation? J Heart Transplant 6(5), 293, 1987.

Katz, MR; Barnhart, GR; Szentpetery, S; et al.: Cardiac Transplantation Without Maintenance Steroids. Transplant Proc 20(1), Suppl 1, 751, 1988.

Ellenbogen, K; Szentpetery, S; Katz, MR: Reversibility of Prolonged Chronotropic Dysfunction with Theophylline Following Orthotopic Cardiac Transplantation. Am Heart J 116(1), 202, 1988.

Katz, MR; Barnhart, GR; Johnson, D; Lower, RR: Homograft Replacement of Single Aortic Valve Cusp: 22 Years Follow-up. J Cardiac Surg 3:297, Suppl, 1988.

Mack,MJ; Brown,PB; Houser,F; Katz,MR; et al.: On-Pump Versus Off-Pump Coronary Artery Bypass Surgery in a Matched Sample of Women. Circulation 110[suppl II]:II-1-II-6, 2004

Argenziano,M; Katz,M, Bonatti,J;et al.: Results of the Prospective Multicenter Trial of Robotically Assisted Totally Endoscopic Coronary Artery Bypass Grafting. Ann Thorac Surg 2006;81:1666-75

Katz,M; Van Praet,F; de Canniere,D; Murphy,D; Siwek,L; Srivastava,S; Seshadri-Kreaden,U; Friedrich,G; Bonnatti,J: Integrated Coronary Revascularization: Percutaneous Coronary Intervention plus Robotic Totally Endoscopic Coronary Artery Bypass. Circulation 2006;114;473-476

Stein,H; Smith,J; Robinson, J; Katz, MR: Target Vessel Detection and Coronary Anastomosis Assessment by Intraoperative 12-MHz Ultrasound. Ann Thorac Surg 2006;82:1078-84

Palmer,G; Herbert,M; Prince,S; Williams,J; Magee,M; Brown,P; Katz,M; Mack,M: Coronary Artery
Revascularization (CARE) Registry: An Observational Study of On-Pump and Off-Pump Coronary
Artery Revascularization. Ann Thorac Surg 2007; 83:986-992


PRESENTATIONS:

Pretransplant Transfusions in Cardiac Allograft Recipients. 57th Scientific Session of the American Heart Association, Miami Beach, Florida, 1984

Surgical Complications in Cardiac Transplant Recipients. 22nd Annual Meeting of the Humera Surgical Society, Park City, Utah, 1986.

Homograft Replacement of Single Aortic Valve Cusps: 22 Year Follow-Up. 4th Scientific Session International Symposium on Cardiac Bioprostheses, Coronado, California, 1988.

Reduction in Adverse Effects in Cardiac Transplant Recipients With Steroid Free Maintenance Immunosuppression. 8th Annual Scientific Session International Society for Heart Transplantation, Los Angeles, California, 1988.

Mechanical Bridge to Cardiac Transplantation. 27th Annual Meeting of the Humera Surgical Society, Phoenix, Arizona, 1991.

Management of Sensitized LVAD Patients Awaiting Transplantation. 10th Annual Heartmate Investigation Meeting, Phoenix, Arizona, October 1997.

Drug Eluting Stents: Counterpoint. HCA Clinical Cardiovascular Management Network Annual Meeting. Tampa, Florida, October 2002.

U.S. daVinci TECAB Trial. 21st Congress of the Italian Society of Cardiac Surgery, Rome, Italy November 2002

U.S. Multi-Center TECAB Trial. 2nd EACTS/ESTS Joint meeting. Vienna, Austria, October 2003


Totally Endoscopic Coronary Artery Bypass Surgery – A learning curve analysis. 40th Annual Meeting of the Humera Surgical Society, Richmond, Virginia, May 2004.

Masters Course on Robotic Cardiac Surgery. 14th International Congress of the Society of Laparoendoscopic Surgeons, San Diego, California, September 14, 2005

Robotic Cardiac Surgery. Surgical Grand Rounds, Hackensack University Medical Center, Hackensack, New Jersey, October 11, 2005

Integrated Coronary Revascularizaton: Percutaneous Coronary Intervention plus Robotic Totally Endoscopic Coronary Artery Bypass; American Heart Association 2005 Scientific Sessions, Dallas, Texas, November 16, 2005

Drug Eluting Stent or Robotic Coronary Artery Bypass, that is the question. 1st International Symposium on Robotic Surgery, Chicago, Illinois October 5, 2006

The Impact of Robotic Surgery on Length of Stay. 1st International Symposium on Robotic Surgery, Chicago, Illinois October 5, 2006

Current One-Year Clinical Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: The CARE (Coronary Artery Revascularization) Study. STS Advances in Quality and Outcomes Meeting. Denver, Colorado October 2006